Learning Outcomes
1.
Graduates will be able to define and address regulatory and health technology assessment issues and risks specific to the medical technology and pharmaceutical industries, and propose effective evidence-based solutions, through the application of rigorous analysis and critical thinking.
- Leaders
- Scholars
2.
Graduates will reflect on and critique the role of ethics in the medical technology and pharmaceutical industries and develop a personal ethical framework for leading within these organisations.
- Professionals
3.
Graduates will develop a thorough knowledge and understanding of the national and global arena in which medical technology, pharmaceutical and other therapeutic products are developed, regulated, priced and marketed.
- Scholars
4.
Graduates will interact and collaborate with others to communicate medical technology and pharmaceutical business information effectively across different channels and with various stakeholders.
- Professionals
- Global Citizens
5.
Graduates will develop the capacity to design, manage and lead innovative projects in the medical technology and pharmaceutical industries.
- Leaders
Available in Program(s) Single degree program(s) in which this specialisation is available:
Master of Business Administration - MBA8625 - Business Administration (Specialised)
Specialisation Structure24 Units of Credit:
Students must complete 24 UOC.
Specialisation Prescribed Electives
Students must take at least 24 UOC of the following courses.
Prescribed Electives
Students can take up to 12 UOC from electives listed in any of the other specialisations offered in MBAX (Change, Technology, Social Impact and Finance).
Pre-2019 Handbook Editions
Access past handbook editions (2018 and prior)